| 0.10 Data as of May 23 |  0.00 / 0.00%Today’s Change | 0.08 Today|||52-Week Range 2.95 | -81.65% Year-to-Date |
| Previous close | 0.10 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 26,279 |
| Market cap | $791.1K |
| Dividend yield | -- |
| Earnings growth (last year) | +72.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -68.79% |
| P/E ratio | -- |
| Price/Sales | 110.75 |
| Price/Book | -- |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $26.0K |
| Annual profit (last year) | -$1.4M |
| Net profit margin | -5,321.67% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President, CEO, COO, CAO & Controller Michael Moshe Cohen |
Chief Financial Officer Thomas Peter Monahan |
Corporate headquarters Hawthorne, New Jersey |
.
